by Eric Christianson | May 24, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
When you are studying for your exams, be sure to take a good, hard look at paroxetine. While it can be effective for anxiety disorders, panic disorder, depression, and PTSD, its pharmacokinetic and adverse effect profile creates several important clinical...
by Eric Christianson | May 13, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Selective serotonin reuptake inhibitors (SSRIs) are among the most frequently prescribed medication classes in clinical practice. While they are generally considered safe and effective, clinicians should remain aware of several important drug interactions that can...
by Eric Christianson | Sep 8, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
In this blog post, I want to share some important SSRI clinical pearls that help clinicians decide which of these antidepressants to use. Note that these clinical practice pearls are good examples of some testable items that may show up on your board exam 🙂 Sertraline...
by Eric Christianson | Jul 21, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Paroxetine is from the family of SSRIs (selective serotonin reuptake inhibitors. It has been around for a long time and is indicated for depression, anxiety, and many other psychiatric indications just like other SSRIs. It doesn’t get much love from healthcare...
by Eric Christianson | May 5, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls, Women’s and Men’s Health Medication and Disease State Clinical Pearls
Is it safe for women to breastfeed while taking antidepressants? According to a CDC report from 2020, ~10.3% of women ages 18-39 take antidepressants, and the number of people diagnosed with depression and taking antidepressants continues to rise. In this article, we...
